Olink Proseek Multiplex Oncology II^96x96

Olink Bioscience has launched Proseek Multiplex Oncology II^96x96, a new human protein biomarker panel for cancer research. This product is part of the ongoing development of the Proseek platform, expanding the library of unique biomarkers available and complementing existing panels directed against cardiovascular and inflammatory diseases, the company said in a statement. The panel offers high-throughput multiplex immunoassays that measure 92 cancer-related proteins across 96 samples simultaneously using only one microliter of serum, plasma, or almost any other type of biological sample. Proseek Multiplex is based on the proprietary proximity extension assay technology developed by Olink. The new panel improves on Proseek Multiplex Oncology 1 v2^96x96 by offering 60 completely new oncology-focused biomarker assays.